Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,310,718
in 4 filings, $1.2M under 10b5-1 plans

Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Andrade Robert −$884K CHIEF FINANCIAL OFFICER sold 26% of stake
  2. Brughera Marco Maria −$160K Director sold 100% of stake
  3. Sayad Pierre Sargis −$146K Chief Medical Officer sold 56% of stake
  4. Raykov Rosty −$121K Former Director sold 7% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-31 Evans Terry L Chief Commercial Officer Option exercise +171 18,627
2026-03-31 Evans Terry L Chief Commercial Officer Grant or award · Stock Options +120,000 $5.77 $692K 270,000
2026-03-31 Hackman Jeffrey S. Chief Executive Officer Option exercise +16,695 45,405
2026-03-31 Hackman Jeffrey S. Chief Executive Officer Option exercise +1,159 46,564
2026-03-31 Hackman Jeffrey S. Chief Executive Officer Grant or award · Stock Options +200,000 $5.77 $1.2M 725,000
2026-03-31 Raykov Rosty Director Grant or award 10b5-1 +5,208 109,204
2026-03-31 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +14,724 271,380
2026-03-31 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +2,213 273,593
2026-03-31 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award · Stock Options +120,000 $5.77 $692K 921,045
2026-03-28 Cioffi Christiana Marie Chief Strategy Officer Option exercise +1,901 23,865
2026-03-28 Sayad Pierre Sargis Chief Medical Officer Option exercise +2,052 20,679
2026-03-28 Evans Terry L Chief Commercial Officer Option exercise +2,052 20,679
2026-03-28 Hackman Jeffrey S. Chief Executive Officer Option exercise +13,943 60,507
2026-03-28 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +12,270 285,863
2026-03-26 Cioffi Christiana Marie Chief Strategy Officer Option exercise +4,700 $4.23 $20K 4,700
2026-03-26 Cioffi Christiana Marie Chief Strategy Officer Option exercise · Stock Options −4,700 $4.23 $20K 145,300
2026-03-26 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +13,072 $5.10 $67K 256,656
2026-03-26 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise · Stock Options −13,072 $5.10 $67K 801,045
2026-03-02 Raykov Rosty Director Option exercise 10b5-1 +15,598 $2.45 $38K 114,075
2026-03-02 Raykov Rosty Director Sale 10b5-1 −10,079 $8.36 $84K 103,996

Page 5 of 8 · 159 trades